GSK Japan Foresees 5% Annual Growth by 2026: President Lirette

GSK Japan President Paul Lirette The Japan arm of GlaxoSmithKline saw its revenue rise 4% in 2021 over the previous year and aims for a compound annual growth rate (CAGR) of 5% by 2026, local president Paul Lirette said at...read more